August 17, 2016

Why CareShare?

Our CareShare 100% IVF Refund Program was developed to help reduce the financial burden associated with In Vitro Fertilization (IVF) by providing patients with a plan that allows for multiple IVF cycles, therefore increasing the chance of delivering a baby. “CareShare is built on RMANJ’s successful, unique, and award-winning treatment paradigm,” says Dr. Leo Doherty. “This [Read more]

August 15, 2016

Are Frozen Embryo Transfers More Successful for PCOS Patients?

Reading through the table of contents from yesterday’s issue of The New England Journal of Medicine, I was interested to find an article entitled “Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome.”  Having many patients with PCOS, I was of course interested to see whether this large study of over 1500 women diagnosed [Read more]

August 11, 2016

Reducing the Financial & Emotional Stress on Fertility Patients

July 25 marked the 38th anniversary of the birth of Louise Brown, the first baby conceived through in vitro fertilization, or IVF. Almost four decades ago, the field of reproductive endocrinology and fertility care brought new hope and solutions to those having trouble having a baby or staying pregnant. Since Louise Brown, it’s estimated that [Read more]

How much does the CareShare Program cost?

For many, the cost of IVF creates a significant financial barrier to having a family. “While some may find the financial resources, the risk of failure and having nothing to show for the money spent if unsuccessful keeps many of our patients from entering care,” says Dr. Thomas Molianro. “The CareShare Program was specifically designed [Read more]

August 9, 2016

Going for Gold: Lessons from Rio

Late one evening this past weekend I was sitting with my wife and dog watching the United States athletes compete in various events at the 2016 Olympic Games in Rio. There was a fascinating recurring theme: that of family. Whether it is the support of family bringing athletes through challenging times or the lack of [Read more]

August 7, 2016

Lack of Evidence Linking IVF & Long-Term Risk of Breast Cancer

Breast cancer is the most common malignancy world-wide among women. Long-term follow-up studies for risk of breast cancer after IVF treatment have raised concerns but have ultimately been inconclusive due to the limited follow-up. Further, association studies in infertility often compare infertile women to non-infertile women, which is not an ideal comparison group when attempting [Read more]

August 4, 2016

How does the RMA CareShare IVF Refund Program Work?

At the core our RMANJ’s CareShare program is a proven infertility treatment system that has generated IVF success rates well over the US average for more than a decade. Still, not every patient experiences success in the same way. The CareShare program was designed to help reduce the financial stress and worry that many of [Read more]

July 28, 2016

Happy Birthday Louise Brown

The world’s first birth after in vitro fertilization (IVF) turned 38 years old this past Monday– Louise Brown was born at Oldham General Hospital in England on July, 25 1978. Making it a family affair, her sister Natalie Brown was born four years later and was the world’s fortieth IVF baby. These “medical miracles” were [Read more]

July 21, 2016

Is The CareShare 100% IVF Refund Program Right For You?

RMA’s new 100% financial guarantee program, CareShare, offers patients the opportunity of multiple IVF cycles for a single package price. Guaranteeing enrolled patients a live birth or 100% refund of their program fees paid if unsuccessful, helping them to pursue other family building options. Sounds great, right? A program designed to share in the financial risk with the [Read more]

July 14, 2016

Response to recent study “Mitochondrial DNA levels as a marker of embryo viability in IVF”

Recent research into embryo assessment techniques, including data presented at ESHRE this year [Mitochondrial DNA levels as a marker of embryo viability in IVF], suggest that mitochondrial DNA content in the embryo may be predictive of its ability to produce a live birth.  However, these studies compared outcomes between patients, which is not how the [Read more]